The Mosaic
MOS
19.97
-0.97
-4.63%
The Mosaic
US · MOS
#1826 by market cap
Listed 1970
19.97
-0.97
-4.63%
Live - 5344 symbols - heartbeat 263s ago
· 2026-10-08 06:54
Pre-market
20.01
+0.18%
After-hours
20.09
+0.60%
Overnight
19.97
0.00%
- Market cap
- 6.35B
- P/E (TTM)i
- -9.94
- P/Bi
- 0.55
- EPSi
- 1.70
- Div yieldi
- 4.41%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on MOS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.82, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.36% YoY
Margins
- Gross margin
- 15.78%
- Operating margin
- 8.95%
- Net margin
- 4.49%
Key ratios & quality
- Enterprise valuei
- 11.19B
- Altman Z-Scorei
- 1.82
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.59B | 8.91B | 8.68B | 12.36B | 19.13B | 13.70B | 11.12B | 12.05B |
| Gross profit | 1.50B | 897.30M | 1.06B | 3.20B | 5.76B | 2.21B | 1.51B | 1.90B |
| Selling & admin expenses | 341.10M | 354.10M | 371.50M | 430.50M | 498.00M | 500.50M | 496.90M | 533.90M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 928.30M | 367.20M | 412.90M | 2.63B | 4.79B | 1.28B | 621.50M | 1.08B |
| Pretax profit | 551.50M | -1.26B | 180.90M | 2.22B | 4.64B | 1.33B | 315.40M | 1.21B |
| Tax | 77.10M | -224.70M | -578.50M | 597.70M | 1.22B | 177.00M | 186.70M | 639.80M |
| Net profit | 469.90M | -1.09B | 665.60M | 1.63B | 3.61B | 1.21B | 202.00M | 575.40M |
| Basic EPS | 1 | -3 | 2 | 4 | 10 | 4 | 1 | 2 |
| Diluted EPS | 1.22 | -2.78 | 1.75 | 4.27 | 10.06 | 3.50 | 0.55 | 1.70 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.62B | 3.01B | 3.45B | 2.97B | 3.00B | 2.82B |
| Gross profit | 488.40M | 518.60M | 552.30M | 342.60M | 235.60M | 214.70M |
| Selling & admin expenses | 122.60M | 167.20M | 125.50M | 118.60M | 135.90M | 131.60M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 338.50M | 244.40M | 339.80M | 156.00M | -140.30M | -29.30M |
| Pretax profit | 312.80M | 564.30M | 599.30M | -263.50M | -285.90M | -300.90M |
| Tax | 63.30M | 146.00M | 175.50M | 255.00M | -31.00M | -33.80M |
| Net profit | 250.00M | 419.70M | 424.10M | -518.40M | -254.50M | -265.50M |
| Basic EPS | 1 | 1 | 1 | -2 | -1 | -1 |
| Diluted EPS | 0.75 | 1.29 | 1.29 | -1.64 | -0.81 | -0.86 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.24B | 3.72B | 3.52B | 5.33B | 6.56B | 4.75B | 4.50B | 5.24B |
| Cash & ST investments | 847.70M | 519.10M | 574.00M | 769.50M | 735.40M | 348.80M | 272.80M | 276.60M |
| Inventory | 2.27B | 2.08B | 1.74B | 2.74B | 3.54B | 2.52B | 2.55B | 3.36B |
| Total assets | 20.12B | 19.30B | 19.79B | 22.04B | 23.39B | 23.03B | 22.92B | 24.48B |
| Total current liabilities | 2.48B | 2.59B | 3.15B | 4.79B | 5.53B | 3.87B | 4.17B | 3.98B |
| Short-term debt | 37.50M | 155.90M | 568.30M | 959.10M | 1.26B | 595.10M | 936.30M | 862.60M |
| Long-term debt | 4.49B | 4.53B | 4.07B | 3.38B | 2.41B | 3.23B | 3.33B | 4.25B |
| Total liabilities | 9,514,500,000.00 | 9,930,900,000.00 | 10,034,600,000.00 | 11,287,900,000.00 | 11,191,800,000.00 | 10,600,000,000.00 | 11,309,300,000.00 | 12,245,900,000.00 |
| Total equity | 10.60B | 9.37B | 9.76B | 10.75B | 12.19B | 12.43B | 11.61B | 12.23B |
| Retained earnings | 11.06B | 9.92B | 10.51B | 12.01B | 14.20B | 14.24B | 13.93B | 14.18B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.59B | 5.02B | 5.08B | 5.24B | 5.34B | 5.43B |
| Cash & ST investments | 259.20M | 286.20M | 153.30M | 276.60M | 281.80M | 294.00M |
| Inventory | 2.78B | 3.07B | 3.28B | 3.36B | 3.42B | 3.67B |
| Total assets | 23.17B | 24.30B | 24.67B | 24.48B | 24.57B | 24.64B |
| Total current liabilities | 4.09B | 4.42B | 4.45B | 3.98B | 4.29B | 4.06B |
| Short-term debt | 1.30B | 1.12B | 1.25B | 862.60M | 1.31B | 1.16B |
| Long-term debt | 3.33B | 3.33B | 3.37B | 4.25B | 4.27B | 4.77B |
| Total liabilities | 11,249,000,000.00 | 11,720,200,000.00 | 11,730,500,000.00 | 12,245,900,000.00 | 12,610,700,000.00 | 13,005,800,000.00 |
| Total equity | 11.92B | 12.58B | 12.94B | 12.23B | 11.96B | 11.63B |
| Retained earnings | 14.09B | 14.50B | 14.85B | 14.18B | 13.86B | 13.58B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.41B | 1.10B | 1.58B | 2.19B | 3.94B | 2.41B | 1.30B | 824.80M |
| Depreciation & amortization | 883.90M | 882.70M | 847.60M | 812.90M | 933.90M | 960.60M | 1.03B | 1.05B |
| Free cash flow | 455.30M | -176.80M | 412.00M | 898.40M | 2.69B | 1.00B | 47.40M | -534.60M |
| Dividends paid | -38.50M | -67.20M | -75.80M | -103.70M | -197.70M | -351.60M | -270.70M | -280.40M |
| Stock buybacks / issuance | -- | -149.90M | 0 | -410.90M | -1.67B | -756.00M | -235.40M | 0 |
| Ending cash balance | 871.00M | 532.30M | 594.40M | 786.30M | 754.10M | 360.80M | 305.00M | 298.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 42.90M | 609.50M | 228.50M | -56.10M | 104.20M | 167.40M |
| Depreciation & amortization | 243.00M | 261.70M | 277.00M | 268.20M | 316.60M | 292.10M |
| Free cash flow | -297.90M | 304.90M | -135.90M | -405.70M | -252.60M | -152.90M |
| Dividends paid | -70.90M | -70.10M | -69.50M | -69.90M | -70.80M | -69.90M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 278.70M | 302.40M | 177.30M | 298.60M | 299.00M | 305.80M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.70 | -10.90 | 7.10 | 16.16 | 31.62 | 9.57 | 1.47 | 4.59 |
| ROA %i | 2.43 | -5.42 | 3.41 | 7.80 | 15.78 | 5.02 | 0.76 | 2.28 |
| ROIC %i | 4.12 | -6.34 | 5.63 | 11.96 | 23.87 | 7.95 | 1.93 | 4.09 |
| 5-year avg ROE %i | 5.15 | 1.14 | 0.58 | 3.19 | 9.73 | 10.71 | 13.18 | 12.68 |
| EBIT margin %i | 8.00 | -11.68 | 4.55 | 19.58 | 25.16 | 11.06 | 4.90 | 12.07 |
| FCF / sales %i | 4.75 | -- | 4.75 | 7.27 | 14.06 | 7.34 | 0.43 | -- |
| Current ratioi | 1.71 | 1.43 | 1.12 | 1.11 | 1.18 | 1.22 | 1.08 | 1.32 |
| Quick ratioi | 0.74 | 0.58 | 0.52 | 0.51 | 0.47 | 0.49 | 0.39 | 0.40 |
| Debt / assetsi | 22.51 | 24.92 | 24.01 | 19.99 | 16.28 | 17.34 | 19.41 | 21.57 |
| LT debt / equityi | 43.20 | 50.65 | 43.66 | 32.50 | 21.13 | 27.66 | 30.60 | 36.55 |
| Interest coveragei | 3.56 | -4.82 | 1.84 | 12.45 | 28.50 | 8.02 | 2.37 | 6.02 |
| Revenue CAGR (3Y) %i | 2.53 | 7.53 | 5.42 | 8.83 | 29.01 | 16.41 | -3.45 | -14.27 |
| Net income CAGR (3Y) %i | -22.26 | -- | -- | 51.39 | -- | 20.48 | -52.49 | -46.76 |
| FCF CAGR (3Y) %i | -24.02 | -- | 52.84 | 25.43 | -- | 34.60 | -62.49 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.09 | 7.80 | 10.00 | 4.59 | 0.38 | -5.34 |
| ROA %i | 1.60 | 4.01 | 5.13 | 2.28 | 0.19 | -2.61 |
| ROIC %i | 2.83 | 6.51 | 8.13 | 4.09 | 0.97 | -2.96 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.47 | 13.07 | 16.01 | 12.07 | 6.99 | 0.12 |
| FCF / sales %i | 1.92 | 0.04 | -- | -- | -- | -- |
| Current ratioi | 1.12 | 1.14 | 1.14 | 1.32 | 1.25 | 1.34 |
| Quick ratioi | 0.38 | 0.38 | 0.33 | 0.40 | 0.36 | 0.35 |
| Debt / assetsi | 20.82 | 19.04 | 19.48 | 21.57 | 23.45 | 24.67 |
| LT debt / equityi | 29.93 | 28.20 | 27.81 | 36.55 | 37.72 | 42.93 |
| Interest coveragei | 3.69 | 6.42 | 8.01 | 6.02 | 3.41 | 0.06 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Phosphates is the largest reported line at 44.13% of revenue, across 4 reported segments.
- No single line clears half of revenue; Mosaic Fertilizantes is next at 36.61%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Phosphates44.13%
Mosaic Fertilizantes36.61%
Potash23.03%
Quote time 2026-10-08 06:54:14 · For reference only, not investment advice and not tailored to your situation.